Evidence map›Paper›PMID 41248424›Full record

ArticleBMJ open2025

Effect of the

Peder Af Geijerstam, Emir Johansson, Siri Fägerstam, Jason Hy Wu, Bijar Ghafouri, Karin Karlsson, Lana Hebib, Lisa Kastbom, Patrik Wennberg, Emelie Gustafson Hedov and 3 more

Registry-linked trialAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05977218 (DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05977218 narecruitingnot on this map

DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial

TypeinterventionalSponsorLinkoeping UniversityRan2025 to 2031Enrolled900ConditionsType 2 DiabetesArmsFoodSwitch
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Peder Af GeijerstamDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden peder.af.geijerstam@liu.se.ORCID http://orcid.org/0000-0001-6038-5131
Emir JohanssonDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.
Siri FägerstamDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0009-0002-8208-6321
Jason Hy WuThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Bijar GhafouriDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0002-6396-5104
Karin KarlssonDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-5029-1086
Lana HebibDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0009-0007-6816-8052
Lisa KastbomDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.
Patrik WennbergDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Emelie Gustafson HedovDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Maria StorgärdsMinForskning AB, Uppsala, Sweden.
Johan SundströmThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Karin RådholmDepartment of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA healthy diet improves glycaemic control and reduces cardiovascular risk in type 2 diabetes (T2D). However, access to dietitians is limited. Several countries have implemented mandatory interpretive front-of-pack labelling to guide consumers towards healthier food choices, but Sweden has not. Smartphone applications may offer an alternative platform to provide such information. This study evaluates the dietary and clinical impact of a novel application providing interpretive labelling to Swedish adults with T2D. METHODS AND ANALYSIS: This is a fully decentralised randomised controlled trial. 900 individuals with T2D for ≥2 years who regularly shop for groceries will be recruited via general practices and community advertisements. Participants will be randomised to receive either: (1) access to the ETHICS AND DISSEMINATION: The trial has received ethical approval from the Swedish Ethical Review Authority (2023-06622-01, 2024-06668-02, 2024-07357-02 and 2025-01095-02) and is performed in line with World Medical Association Declaration of Helsinki and the General Data Protection Regulation. Results will be published in a peer-reviewed international journal. TRIAL REGISTRATION NUMBER: NCT05977218.

Indexed as

Diabetes Mellitus, Type 2Diet, HealthyFood LabelingMobile ApplicationsAdultFemaleGlycated HemoglobinHumansMaleMiddle AgedQuality of LifeRandomized Controlled Trials as TopicSmartphoneSwedenGlycated HemoglobinDiabetes Mellitus, Type 2Mobile ApplicationsNUTRITION & DIETETICSRandomized Controlled Trial

Identifiers

PMID41248424
PMCPMC12917363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.